CN105124705A - Inonotus obliquus beverage - Google Patents
Inonotus obliquus beverage Download PDFInfo
- Publication number
- CN105124705A CN105124705A CN201510656996.6A CN201510656996A CN105124705A CN 105124705 A CN105124705 A CN 105124705A CN 201510656996 A CN201510656996 A CN 201510656996A CN 105124705 A CN105124705 A CN 105124705A
- Authority
- CN
- China
- Prior art keywords
- extract
- inonotus obliquus
- beverage
- percentage
- weight
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241000414067 Inonotus obliquus Species 0.000 title claims abstract description 42
- 235000013361 beverage Nutrition 0.000 title claims abstract description 22
- 239000000284 extract Substances 0.000 claims abstract description 29
- 235000020710 ginseng extract Nutrition 0.000 claims abstract description 14
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 12
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 33
- 241000233866 Fungi Species 0.000 claims description 13
- 108010059892 Cellulase Proteins 0.000 claims description 11
- 241000123107 Phellinus Species 0.000 claims description 11
- 229940106157 cellulase Drugs 0.000 claims description 11
- 235000021552 granulated sugar Nutrition 0.000 claims description 11
- 241000027355 Ferocactus setispinus Species 0.000 claims description 6
- 230000000694 effects Effects 0.000 abstract description 4
- 206010011224 Cough Diseases 0.000 abstract description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 abstract description 2
- 208000019693 Lung disease Diseases 0.000 abstract description 2
- 206010028980 Neoplasm Diseases 0.000 abstract description 2
- 208000026435 phlegm Diseases 0.000 abstract description 2
- 241000222336 Ganoderma Species 0.000 abstract 1
- 240000000588 Hericium erinaceus Species 0.000 abstract 1
- 235000007328 Hericium erinaceus Nutrition 0.000 abstract 1
- 230000036039 immunity Effects 0.000 abstract 1
- 235000015097 nutrients Nutrition 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- 241000289669 Erinaceus europaeus Species 0.000 description 5
- 235000018185 Betula X alpestris Nutrition 0.000 description 3
- 235000018212 Betula X uliginosa Nutrition 0.000 description 3
- 230000001093 anti-cancer Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- JMSVCTWVEWCHDZ-UHFFFAOYSA-N syringic acid Chemical compound COC1=CC(C(O)=O)=CC(OC)=C1O JMSVCTWVEWCHDZ-UHFFFAOYSA-N 0.000 description 2
- BQPPJGMMIYJVBR-UHFFFAOYSA-N (10S)-3c-Acetoxy-4.4.10r.13c.14t-pentamethyl-17c-((R)-1.5-dimethyl-hexen-(4)-yl)-(5tH)-Delta8-tetradecahydro-1H-cyclopenta[a]phenanthren Natural products CC12CCC(OC(C)=O)C(C)(C)C1CCC1=C2CCC2(C)C(C(CCC=C(C)C)C)CCC21C BQPPJGMMIYJVBR-UHFFFAOYSA-N 0.000 description 1
- CHGIKSSZNBCNDW-UHFFFAOYSA-N (3beta,5alpha)-4,4-Dimethylcholesta-8,24-dien-3-ol Natural products CC12CCC(O)C(C)(C)C1CCC1=C2CCC2(C)C(C(CCC=C(C)C)C)CCC21 CHGIKSSZNBCNDW-UHFFFAOYSA-N 0.000 description 1
- XYTLYKGXLMKYMV-UHFFFAOYSA-N 14alpha-methylzymosterol Natural products CC12CCC(O)CC1CCC1=C2CCC2(C)C(C(CCC=C(C)C)C)CCC21C XYTLYKGXLMKYMV-UHFFFAOYSA-N 0.000 description 1
- FPTJELQXIUUCEY-UHFFFAOYSA-N 3beta-Hydroxy-lanostan Natural products C1CC2C(C)(C)C(O)CCC2(C)C2C1C1(C)CCC(C(C)CCCC(C)C)C1(C)CC2 FPTJELQXIUUCEY-UHFFFAOYSA-N 0.000 description 1
- 241000222485 Agaricales Species 0.000 description 1
- 241000222382 Agaricomycotina Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- BKLIAINBCQPSOV-UHFFFAOYSA-N Gluanol Natural products CC(C)CC=CC(C)C1CCC2(C)C3=C(CCC12C)C4(C)CCC(O)C(C)(C)C4CC3 BKLIAINBCQPSOV-UHFFFAOYSA-N 0.000 description 1
- LOPKHWOTGJIQLC-UHFFFAOYSA-N Lanosterol Natural products CC(CCC=C(C)C)C1CCC2(C)C3=C(CCC12C)C4(C)CCC(C)(O)C(C)(C)C4CC3 LOPKHWOTGJIQLC-UHFFFAOYSA-N 0.000 description 1
- CAHGCLMLTWQZNJ-UHFFFAOYSA-N Nerifoliol Natural products CC12CCC(O)C(C)(C)C1CCC1=C2CCC2(C)C(C(CCC=C(C)C)C)CCC21C CAHGCLMLTWQZNJ-UHFFFAOYSA-N 0.000 description 1
- 241000222341 Polyporaceae Species 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- QBSJHOGDIUQWTH-UHFFFAOYSA-N dihydrolanosterol Natural products CC(C)CCCC(C)C1CCC2(C)C3=C(CCC12C)C4(C)CCC(C)(O)C(C)(C)C4CC3 QBSJHOGDIUQWTH-UHFFFAOYSA-N 0.000 description 1
- YGANSGVIUGARFR-UHFFFAOYSA-N dipotassium dioxosilane oxo(oxoalumanyloxy)alumane oxygen(2-) Chemical compound [O--].[K+].[K+].O=[Si]=O.O=[Al]O[Al]=O YGANSGVIUGARFR-UHFFFAOYSA-N 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 150000002224 folic acids Chemical class 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000002218 hypoglycaemic effect Effects 0.000 description 1
- CAHGCLMLTWQZNJ-RGEKOYMOSA-N lanosterol Chemical compound C([C@]12C)C[C@@H](O)C(C)(C)[C@H]1CCC1=C2CC[C@]2(C)[C@H]([C@H](CCC=C(C)C)C)CC[C@@]21C CAHGCLMLTWQZNJ-RGEKOYMOSA-N 0.000 description 1
- 229940058690 lanosterol Drugs 0.000 description 1
- 229910052627 muscovite Inorganic materials 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- YQUVCSBJEUQKSH-UHFFFAOYSA-N protochatechuic acid Natural products OC(=O)C1=CC=C(O)C(O)=C1 YQUVCSBJEUQKSH-UHFFFAOYSA-N 0.000 description 1
- YIBXWXOYFGZLRU-UHFFFAOYSA-N syringic aldehyde Natural products CC12CCC(C3(CCC(=O)C(C)(C)C3CC=3)C)C=3C1(C)CCC2C1COC(C)(C)C(O)C(O)C1 YIBXWXOYFGZLRU-UHFFFAOYSA-N 0.000 description 1
- -1 triterpene compound Chemical class 0.000 description 1
- WKOLLVMJNQIZCI-UHFFFAOYSA-N vanillic acid Chemical compound COC1=CC(C(O)=O)=CC=C1O WKOLLVMJNQIZCI-UHFFFAOYSA-N 0.000 description 1
- TUUBOHWZSQXCSW-UHFFFAOYSA-N vanillic acid Natural products COC1=CC(O)=CC(C(O)=O)=C1 TUUBOHWZSQXCSW-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Preparation or treatment thereof
- A23L2/38—Other non-alcoholic beverages
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Medicines Containing Plant Substances (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
The invention discloses an inonotus obliquus beverage. The inonotus obliquus beverage is prepared from 0.5% to 2% of inonotus obliquus extract, 0.5% to 2% of ginseng extract, 0.1% to 1% of lucid ganoderma extract, 0.1% to 1% of hericium erinaceus extract and the balance water. The multiple kinds of extract including the inonotus obliquus extract, the ginseng extract and the like are scientifically and reasonably matched, various nutrient substances are matched in a balanced mode accordingly, a functional health caring product is formed, and the effects of boosting immunity, clearing damp, reducing phlegm, treating lung diseases, resisting and preventing cancers, relieving cough and the like are achieved.
Description
Technical field
The present invention relates to field of food, particularly relate to a kind of Inonotus obliquus beverage.
Background technology
Inonotus obliquus: Chinese name: fine and soft from birch.Classification system: Fuscoporiaoblique Europe is referred to as chaga.Belong to Eumycota, Basidiomycotina, Hymenomycetes, Agaricales, Polyporaceae.Chinese name: CHAGA.Be a kind of medicinal fungi be born on birch, its fructification presents the black block-shape morphology being similar to carbon.When playing drug effect after Inonotus obliquus 10-15, it can blot the marrow of birch, makes trees withered or died.Inonotus obliquus is mainly distributed in Russia the north, Northern Europe, China Dark Longjiang, Japan (Hokkaido), grows the area of north latitude 40 °-50 ° on the Northern Hemisphere.Inonotus obliquus is Muscovite a kind of Medicinal fungi, and its active ingredient has caused the extensive attention of the state researchers such as the U.S., Japan, Korea S.According to preliminary research, Inonotus obliquus contains Inonotus obliquus alcohol, oxidation triterpene compound, lanosterol, the acid of bolt bacterium, folic acid derivatives, aromatic vanillic acid, syringic acid etc.There is the effects such as anticancer, antiviral, hypoglycemic, resurrection is immune.
Summary of the invention
In view of above-mentioned the deficiencies in the prior art, the object of the present invention is to provide a kind of Inonotus obliquus beverage.
For solving the problems of the technologies described above, technical solution of the present invention comprises:
A kind of Inonotus obliquus beverage, it comprises following component according to percentage by weight:
Inonotus obliquus extract 2%-0.5%;
Ginseng extract 2%-0.5%;
Ganodenna Lucidum P.E 1%-0.1%;
Hedgehog fungus extract 1%-0.1%;
Surplus is water.
Described Inonotus obliquus beverage, wherein, it also comprises following component according to percentage by weight:
Pectase 0.05%-0.01%;
Cellulase 0.1%-0.01%;
Phellinus 0.05%-0.01%;
Granulated sugar 0.05%-0.01%;
Citric acid 0.05%-0.01%.
Described Inonotus obliquus beverage, wherein, it comprises following component according to percentage by weight:
Inonotus obliquus extract 0.5%;
Ginseng extract 0.5%;
Ganodenna Lucidum P.E 0.625%;
Hedgehog fungus extract 0.625%;
Pectase 0.01%;
Cellulase 0.02%;
Phellinus 0.01%;
Granulated sugar 0.01%;
Citric acid 0.01%
Surplus is water.
Described Inonotus obliquus beverage, wherein, it comprises following component according to percentage by weight:
Inonotus obliquus extract 1%;
Ginseng extract 1%;
Ganodenna Lucidum P.E 0.125%;
Hedgehog fungus extract 0.125%;
Pectase 0.02%;
Cellulase 0.01%;
Phellinus 0.03%;
Granulated sugar 0.03%;
Citric acid 0.02%
Surplus is water.
A kind of Inonotus obliquus beverage provided by the invention, the multiple extracts such as Inonotus obliquus extract, ginseng extract are adopted to carry out scientific and reasonable collocation, make various nutriment equilibrium collocation, form a kind of functional health product, there is develop immunitypty, dry, reduce phlegm, treat the effects such as lung disease, anti-cancer and cancer-preventing, cough-relieving.
Detailed description of the invention
The invention provides a kind of Inonotus obliquus beverage, for making object of the present invention, technical scheme and effect clearly, clearly, the present invention is described in more detail below.Should be appreciated that specific embodiment described herein only in order to explain the present invention, be not intended to limit the present invention.
The invention provides a kind of Inonotus obliquus beverage, it comprises according to percentage by weight: the Inonotus obliquus extract of 2%-0.5%, the ginseng extract of 2%-0.5%, the Ganodenna Lucidum P.E of 1%-0.1%, the hedgehog fungus extract of 1%-0.1%; Surplus is water.
In order to further improve quality and the mouthfeel of Inonotus obliquus beverage, the citric acid of the pectase of 0.05%-0.01%, the cellulase of 0.1%-0.01%, the Phellinus of 0.05%-0.01%, the granulated sugar of 0.05%-0.01% and 0.05%-0.01% can also be added.
What it was more detailed is; Inonotus obliquus beverage comprises according to percentage by weight: the Inonotus obliquus extract of 0.5%, the ginseng extract of 0.5%, 0.625% Ganodenna Lucidum P.E, 0.625% hedgehog fungus extract, 0.01% pectase, 0.02% cellulase, the Phellinus of 0.01%, the granulated sugar of 0.01% and 0.01% citric acid, surplus is water.
Further; Inonotus obliquus beverage comprises according to percentage by weight: the Inonotus obliquus extract of 1%, the ginseng extract of 1%, 0.125% Ganodenna Lucidum P.E, 0.125% hedgehog fungus extract, 0.02% pectase, 0.01% cellulase, the Phellinus of 0.03%, the granulated sugar of 0.03% and 0.02% citric acid, surplus is water.
Further; Inonotus obliquus beverage comprises according to percentage by weight: the Inonotus obliquus extract of 1.5%, the ginseng extract of 1.5%, 0.25% Ganodenna Lucidum P.E, 0.25% hedgehog fungus extract, 0.03% pectase, 0.01% cellulase, the Phellinus of 0.01%, the granulated sugar of 0.02% and 0.05% citric acid, surplus is water.
Further; Inonotus obliquus beverage comprises according to percentage by weight: the Inonotus obliquus extract of 2%, the ginseng extract of 2%, 0.5% Ganodenna Lucidum P.E, 0.5% hedgehog fungus extract, 0.05% pectase, 0.03% cellulase, the Phellinus of 0.01%, the granulated sugar of 0.05% and 0.02% citric acid, surplus is water.
Certainly; more than illustrate and be only preferred embodiment of the present invention; the present invention is not limited to enumerate above-described embodiment; should be noted that; any those of ordinary skill in the art are under the instruction of this description; made all equivalently to substitute, obvious variant, within the essential scope all dropping on this description, protection of the present invention ought to be subject to.
Claims (4)
1. an Inonotus obliquus beverage, it comprises following component according to percentage by weight:
Inonotus obliquus extract 2%-0.5%;
Ginseng extract 2%-0.5%;
Ganodenna Lucidum P.E 1%-0.1%;
Hedgehog fungus extract 1%-0.1%;
Surplus is water.
2. Inonotus obliquus beverage according to claim 1, is characterized in that, it also comprises following component according to percentage by weight:
Pectase 0.05%-0.01%;
Cellulase 0.1%-0.01%;
Phellinus 0.05%-0.01%;
Granulated sugar 0.05%-0.01%;
Citric acid 0.05%-0.01%.
3. Inonotus obliquus beverage according to claim 2, is characterized in that, it comprises following component according to percentage by weight:
Inonotus obliquus extract 0.5%;
Ginseng extract 0.5%;
Ganodenna Lucidum P.E 0.625%;
Hedgehog fungus extract 0.625%;
Pectase 0.01%;
Cellulase 0.02%;
Phellinus 0.01%;
Granulated sugar 0.01%;
Citric acid 0.01%
Surplus is water.
4. Inonotus obliquus beverage according to claim 2, is characterized in that, it comprises following component according to percentage by weight:
Inonotus obliquus extract 1%;
Ginseng extract 1%;
Ganodenna Lucidum P.E 0.125%;
Hedgehog fungus extract 0.125%;
Pectase 0.02%;
Cellulase 0.01%;
Phellinus 0.03%;
Granulated sugar 0.03%;
Citric acid 0.02%
Surplus is water.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510656996.6A CN105124705A (en) | 2015-10-14 | 2015-10-14 | Inonotus obliquus beverage |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201510656996.6A CN105124705A (en) | 2015-10-14 | 2015-10-14 | Inonotus obliquus beverage |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105124705A true CN105124705A (en) | 2015-12-09 |
Family
ID=54710579
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201510656996.6A Pending CN105124705A (en) | 2015-10-14 | 2015-10-14 | Inonotus obliquus beverage |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105124705A (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106962730A (en) * | 2017-03-02 | 2017-07-21 | 王玉亭 | A kind of ganoderma lucidum birch tear ginseng stilbene natural plant beverage and preparation method thereof |
| CN107136371A (en) * | 2017-05-16 | 2017-09-08 | 莫力达瓦达斡尔族自治旗兴军农业生态发展有限公司 | Fine and soft mulse of the blue or green juice birch of a kind of barley and preparation method thereof |
| CN109043276A (en) * | 2018-07-13 | 2018-12-21 | 吉林省长寿堂保健品有限公司 | A kind of inonotus obliquus solid beverage and the preparation method and application thereof |
| CN113975305A (en) * | 2021-09-14 | 2022-01-28 | 张志忠 | Traditional Chinese medicine tea and preparation method thereof |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1081843A (en) * | 1992-08-08 | 1994-02-16 | 李晓明 | With the glossy ganoderma and hericium mushroom is the method that raw material is made beverage |
| CN1689460A (en) * | 2004-04-23 | 2005-11-02 | 北京东萱元朝生物技术有限公司 | Beverage capable of lowering and preventing high blood sugar |
| KR20060013065A (en) * | 2004-08-05 | 2006-02-09 | 김진석 | Functional bottled water |
| CN101053438A (en) * | 2007-05-11 | 2007-10-17 | 俞文俊 | Health care beverage |
| CN101317861A (en) * | 2007-06-04 | 2008-12-10 | 付茂康 | Oral liquid for the aged |
-
2015
- 2015-10-14 CN CN201510656996.6A patent/CN105124705A/en active Pending
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1081843A (en) * | 1992-08-08 | 1994-02-16 | 李晓明 | With the glossy ganoderma and hericium mushroom is the method that raw material is made beverage |
| CN1689460A (en) * | 2004-04-23 | 2005-11-02 | 北京东萱元朝生物技术有限公司 | Beverage capable of lowering and preventing high blood sugar |
| KR20060013065A (en) * | 2004-08-05 | 2006-02-09 | 김진석 | Functional bottled water |
| CN101053438A (en) * | 2007-05-11 | 2007-10-17 | 俞文俊 | Health care beverage |
| CN101317861A (en) * | 2007-06-04 | 2008-12-10 | 付茂康 | Oral liquid for the aged |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106962730A (en) * | 2017-03-02 | 2017-07-21 | 王玉亭 | A kind of ganoderma lucidum birch tear ginseng stilbene natural plant beverage and preparation method thereof |
| CN107136371A (en) * | 2017-05-16 | 2017-09-08 | 莫力达瓦达斡尔族自治旗兴军农业生态发展有限公司 | Fine and soft mulse of the blue or green juice birch of a kind of barley and preparation method thereof |
| CN109043276A (en) * | 2018-07-13 | 2018-12-21 | 吉林省长寿堂保健品有限公司 | A kind of inonotus obliquus solid beverage and the preparation method and application thereof |
| CN113975305A (en) * | 2021-09-14 | 2022-01-28 | 张志忠 | Traditional Chinese medicine tea and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Heleno et al. | Fruiting body, spores and in vitro produced mycelium of Ganoderma lucidum from Northeast Portugal: A comparative study of the antioxidant potential of phenolic and polysaccharidic extracts | |
| Elkhateeb | What medicinal mushroom can do | |
| KR20080113175A (en) | Manufacturing method and functional product of functional drink using situation mushroom | |
| CN105124705A (en) | Inonotus obliquus beverage | |
| CN102987511A (en) | Cordyceps militaris solid drink and preparation method thereof | |
| KR102082248B1 (en) | Ginseng concentrate without pesticides, method for preparing thereof, and functional food composition using the same | |
| CN103826473B (en) | Bitter inhibitor and the ginseng composition comprising it | |
| KR20100114348A (en) | Manufacturing method for tea using mate extract | |
| KR101662185B1 (en) | Method for producing chaga mushroom extract containing high concentration of? -glucan | |
| CN104435005A (en) | Method for refining triterpene compound in antrodia | |
| WA et al. | Bioactive potential of some fascinating edible mushrooms Macrolepiota, Russula, Amanita, Vovariella and Grifola as a treasure of multipurpose therapeutic natural product | |
| Shahrajabian et al. | Potential roles of longan as a natural remedy with tremendous nutraceutical values | |
| US20190000905A1 (en) | Gynostemma pentaphyllum fermented extracts comprising Saponins as an active functional food ingredient and preparation method thereof | |
| KR102387371B1 (en) | Fermented Stauntonia hexaphylla with improved antioxidant activity and uses thereof | |
| CN104497158A (en) | Method for extracting jujube polysaccharide | |
| Salwan et al. | Recent developments in shiitake mushrooms and their nutraceutical importance | |
| CN101953467A (en) | Composition containing natto freeze-dried powder and application thereof | |
| CN101214077A (en) | Beverage made from edible fungus sporophore | |
| CN107446766A (en) | A kind of tea wine | |
| KR101897005B1 (en) | Composition for Relieving Hangover Using Ginsenoside Compound K | |
| KR102507651B1 (en) | Fermented Stauntonia hexaphylla for hangover relief, alcoholic liver disease or liver function improvement using fermented enzyme complex solution containing traditional brewery yeast and its manufacturing method | |
| Thomas et al. | Unearthing the therapeutic benefits of culinary‐medicinal mushrooms for humans: Emerging sustainable bioresources of 21st century | |
| Taupiqurrohman et al. | From fermentation to cancer prevention: The anticancer potential of Kombucha | |
| Yao et al. | Evaluation of In Vitro Antioxidant and Antihyperglycemic Activities of Extracts from the Lion's Mane Medicinal Mushroom, Hericium erinaceus (Agaricomycetes) | |
| CN102851164A (en) | Inonotus obliquus dry red wine |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20151209 |
|
| RJ01 | Rejection of invention patent application after publication |